• TCEP Hydrochloride for Protein and LFA Workflows

  2026-09-29

  TCEP hydrochloride provides odorless, water-compatible disulfide reduction for protein preparation, digestion, structural analysis, and redox assays. Used upstream and with appropriate cleanup, it can complement capture-and-release lateral flow designs without being mistaken for the cleavable trigger itself.

• RHO P347L Retinitis Pigmentosa: Endocytosis and Stress

  2026-09-29

  Hang et al. show that the severe RHO P347L retinitis pigmentosa phenotype is linked to defective outer-segment trafficking, enhanced arrestin-associated endocytosis, lysosomal overload, and mitochondrial stress. By comparing humanized P347L and L125R knock-in models with complementary cell-based assays, the study separates mutation-specific degradation mechanisms from shared neuroinflammation and provides a framework for interpreting photoreceptor degeneration.

• Bivalent mRNA–LNP Vaccine Protects Against H5/H7

  2026-09-28

  Wei and colleagues developed a nucleoside-modified bivalent mRNA–LNP vaccine encoding H5N1 and H7N9 hemagglutinins and tested it in SPF chickens. The vaccine induced dose-dependent humoral immunity, protected high-dose groups against homologous and heterologous challenge, reduced viral replication and shedding, and produced transcriptomic signatures associated with Th1 responses and antigen presentation.

• Cell Counting Kit-8 (CCK-8): Reliable Assays

  2026-09-28

  A scenario-driven guide to designing and interpreting CCK-8 cell viability, proliferation, and cytotoxicity experiments. Learn how Cell Counting Kit-8 (CCK-8), SKU K1018, fits practical workflows and where controls and validation remain essential.

• TG003 and the Translational Logic of CLK2 Inhibition

  2026-09-27

  TG003 offers a way to interrogate Clk-dependent phosphorylation and splicing, while ovarian cancer research raises a distinct question: can pharmacological Clk inhibition test CLK2’s role in platinum resistance? This article connects the mechanisms, outlines validation strategies, and defines the limits of current evidence.

• 5-Methyl-CTP for mRNA Synthesis Workflows

  2026-09-26

  5-Methyl-CTP offers a practical way to test whether cytidine modification improves the performance of an in vitro-transcribed mRNA, while keeping transcript design and delivery as separate variables. Here, an outer-membrane-vesicle vaccine study provides a useful delivery context—not evidence that the study used this nucleotide—and a workflow for evaluating the two stages without conflating them.

• Trichostatin A (TSA) in Ferroptosis Research

  2026-09-25

  Trichostatin A (TSA) is a powerful tool for studying how chromatin regulation shapes cancer-cell behavior. This article connects TSA-based HDAC perturbation to emerging evidence on the HDAC3–NRF2–GPX4 ferroptosis axis, while clarifying what the evidence does—and does not—support experimentally.

• IGF2BP3–FZD1/7 Drives TNBC Stemness and Resistance

  2026-09-25

  A 2025 study identifies IGF2BP3 as an m6A reader that stabilizes FZD1 and FZD7 transcripts, promoting β-catenin signaling, cancer stem-like properties, and carboplatin resistance in triple-negative breast cancer. The findings position the IGF2BP3–FZD1/7 axis as a preclinical therapeutic vulnerability and suggest that inhibiting FZD1/7 may sensitize TNBC stem-like cells to carboplatin.

• Solanesol (B8776): Practical Research Workflow

  2026-09-24

  Solanesol is a hydrophobic polyisoprenoid alcohol for biochemical workflows that need a defined, DMSO-compatible research compound, including membrane-related studies and selected enzyme assays. It is insoluble in water and ethanol, so it is not appropriate for preparations that require either solvent or for diagnostic, clinical, or medical use.

• Minoxidil Sulphate: A Channel-Context Framework

  2026-09-24

  Minoxidil sulphate is more than a vasodilator-related reagent: it can help researchers probe potassium-channel-linked responses when interpreted alongside vascular bed, stimulus, and endpoint. This article translates a sepsis study into practical assay-design principles without treating its findings as direct evidence about minoxidil sulphate.

• Angiotensin II Workflows for Vascular Research

  2026-09-23

  Use Angiotensin II to build controlled cell and animal models of vascular signaling, hypertrophy, and remodeling—with practical guidance for dosing, controls, and troubleshooting. The workflow also places AngII-driven disease modeling in context with a 2025 targeted nanoparticle strategy for abdominal aortic aneurysm research.

• NAT1–ENO1–Lactate Axis in Colorectal Cancer

  2026-09-23

  A 2026 MedComm study identifies a NAT1–ENO1–lactate circuit that connects tumor glycolysis with TRAF6-dependent PD-L1 stabilization in colorectal cancer. Its combination of patient data, multi-omics, biochemical analysis, and mouse models suggests that metabolic-state measurements may help explain variation in checkpoint-blockade responses.

• Ferrostatin-1 (Fer-1): Mechanism and Research Use

  2026-09-22

  Ferrostatin-1, also called Fer-1, is a selective ferroptosis inhibitor that suppresses lipid peroxidation and lipid reactive oxygen species. Its nanomolar cellular benchmark supports ferroptosis assays in cancer biology research, neurodegenerative disease models, and related oxidative injury studies.

• From CTD Phospho-Maps to Cysteine Accessibility

  2026-09-22

  A translational framework connecting RNAPII CTD phosphorylation biology with orthogonal cysteine-accessibility measurements using MTSEA-biotin, while defining what the chemistry can—and cannot—claim in a mechanistic workflow.

• Neticonazole Hydrochloride: Research Workflows

  2026-09-21

  Neticonazole Hydrochloride supports two distinct research paths: validated topical antifungal work and exploratory colorectal cancer studies. This practical guide connects diagnosis, formulation, cell-based assays, exosome analysis, and troubleshooting without overstating preclinical oncology evidence.

8063 records 1/538 page Next 12345 下5页 Last page